The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Management of Alcohol Withdrawal Delirium<subtitle>An Evidence-Based Practice Guideline</subtitle>
Abstract
BACKGROUND: Alcohol withdrawal delirium is the most serious manifestation of alcohol withdrawal. Evidence suggests that appropriate care improves mortality, but systematic reviews are unavailable. METHODS: Articles with original data on management of alcohol withdrawal delirium underwent structured review and meta-analysis. RESULTS: Meta-analysis of 9 prospective controlled trials demonstrated that sedative-hypnotic agents are more effective than neuroleptic agents in reducing duration of delirium and mortality, with a relative risk of death when using neuroleptic agents of 6.6. Statistically significant differences among various benzodiazepines and barbiturates were not found. No deaths were reported in 217 patients from trials using benzodiazepines or barbiturates. CONCLUSIONS: Control of agitation should be achieved using parenteral rapid-acting sedative-hypnotic agents that are cross-tolerant with alcohol. Adequate doses should be used to maintain light somnolence for the duration of delirium. Coupled with comprehensive supportive medical care, this approach is highly effective in preventing morbidity and mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oral Sildenafil in the Treatment of Erectile Dysfunction
Goldstein, I., Lue, T. F., Padma-Nathan, H., Rosen, R. C., Steers, W. D., & Wicker, P. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805143382001 · Cited by 2,120
Rules of Evidence and Clinical Recommendations on the Use of Antithrombotic Agents
Sackett, D. L. (1989) · Chest · doi:10.1378/chest.95.2_supplement.2s · Cited by 1,368
Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden Death
Glassman, A. H., & Bigger, J. T. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1774 · Cited by 822
Prevalence, Detection, and Treatment of Alcoholism in Hospitalized Patients
Moore, R. D. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03420030077033 · Cited by 530
Current Status of Benzodiazepines
Koch-Weser, J., Greenblatt, D. J., Shader, R. I., & Abernethy, D. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090705 · Cited by 451
Mayo-Smith, M. F. (1997) · JAMA · doi:10.1001/jama.278.2.144 · Cited by 434
Self-citationThe effect of alcohol on the nervous system.
Víctor, M., & Adams, R. D. (1953) · PubMed · Cited by 308
[Effect of alcohol on the nervous system].
Golovchenko, I. I., & Adamenko, R. I. (1986) · PubMed · Cited by 275
Rules of Evidence and Clinical Recommendations on the Use of Antithrombotic Agents
Cook, D. J., Guyatt, G. H., Laupacis, A., & Sackett, D. L. (1992) · Chest · doi:10.1378/chest.102.4_supplement.305s · Cited by 217
Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans
Greenblatt, D. J., Shader, R. I., Franke, K., MacLaughlin, D. S., Harmatz, J. S., Allen, M. D., Werner, A., & Woo, E. (1979) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600680119 · Cited by 197
Cited by
Barr, J., Fraser, G. L., Puntillo, K., Ely, E. W., Gélinas, C., Dasta, J. F., Davidson, J. E., Devlin, J. W., Kress, J. P., Joffe, A. M., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182783b72 · Cited by 3,765
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease
Thursz, M., Gual, A., Lackner, C., Mathurin, P., Moreno, C., Spahr, L., Sterneck, M., & Cortez-Pinto, H. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.018 · Cited by 943
ACG Clinical Guideline: Alcoholic Liver Disease
Singal, A. K., Bataller, R., Ahn, J., Kamath, P. S., & Shah, V. H. (2018) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.469 · Cited by 835
EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease
European Association for the Study of the Liver (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.04.004 · Cited by 720
Delirium Tremens: Assessment and Management
Grover, S., & Ghosh, A. (2018) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2018.04.012 · Cited by 416
Recognition and Management of Withdrawal Delirium (Delirium Tremens)
Schuckit, M. A. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1407298 · Cited by 374
Vonghia, L., Leggio, L., Ferrulli, A., Bertini, M., Gasbarrini, G., & Addolorato, G. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.06.033 · Cited by 354
Lingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444324 · Cited by 332
“oxazepam) may be preferred, especially where there is concern about accumulation leading to oversedation (Mayo-Smith et al., 2004) (III).”
BackgroundACG Clinical Guideline: Alcohol-Associated Liver Disease
Jophlin, L. L., Singal, A. K., Bataller, R., Wong, R. J., Sauer, B. G., Terrault, N. A., & Shah, V. H. (2024) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002572 · Cited by 292
The alcohol withdrawal syndrome
McKeon, A., Frye, M. A., & Delanty, N. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.128322 · Cited by 269
Introduction: Methods, Commentary, and Summary
ALLEN, M. H., CURRIER, G. W., CARPENTER, D., ROSS, R. W., & DOCHERTY, J. P. (2005) · Journal of Psychiatric Practice · doi:10.1097/00131746-200511001-00002 · Cited by 267
Treatment options for alcoholic and non-alcoholic fatty liver disease: A review
Singh, S., Osna, N. A., & Kharbanda, K. K. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i36.6549 · Cited by 257
Clinical management of alcohol withdrawal: A systematic review
Bharadwaj, B., & Kattimani, S. (2013) · Industrial Psychiatry Journal · doi:10.4103/0972-6748.132914 · Cited by 154
Delirium in the Older Emergency Department Patient: A Quiet Epidemic
Han, J. H., Wilson, A., & Ely, E. W. (2010) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2010.03.005 · Cited by 124
Role of α 2 -Agonists in the Treatment of Acute Alcohol Withdrawal
Muzyk, A. J., Fowler, J. A., Norwood, D. K., & Chilipko, A. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1p575 · Cited by 107
Oldham, M. A., & Ivkovic, A. (2012) · Addiction Science & Clinical Practice · doi:10.1186/1940-0640-7-12 · Cited by 56
Mo, Y., Thomas, M. C., & Karras, G. E. (2016) · Journal of Critical Care · doi:10.1016/j.jcrc.2015.11.022 · Cited by 47
Managing benzodiazepine withdrawal during pregnancy: case-based guidelines
Gopalan, P., Glance, J. B., & Azzam, P. N. (2014) · Archives of Women's Mental Health · doi:10.1007/s00737-013-0388-1 · Cited by 16
“Continuous infusion is utilized clinically in patients with high benzodiazepine requirements during the withdrawal period and for those with autonomic instability; however, no studies show a difference in therapeutic efficacy for continuous infusion, and no comparison studies exist to compare this modality to others f…”
BackgroundLove, K., & Zimmermann, A. E. (2020) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1539 · Cited by 14
Faustmann, T. J., Paschali, M., Kojda, G., Schilbach, L., & Kamp, D. (2025) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-2029-6387 · Cited by 4
(2014) · Työväentutkimus Vuosikirja · Cited by 1
Metadata
- Authors
- Mayo-Smith, M. F.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2004-07-12
- Volume
- 164
- Issue
- 13
- Pages
- 1405
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2112954532
- Cited by
- 418
- References
- 55
- FWCI
- 10.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.